MedTrace Logo

Medicinal Cannabis for Painful HIV Neuropathy

NCT00255580 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2008-02-28

No results posted yet for this study

Summary

The purpose of this study is to determine if medicinal cannabis (marijuana) is safe and effective for treating pain in individuals with HIV-associated distal, sensory-predominant polyneuropathy (DSPN).

Conditions

  • Neuropathic Pain

Interventions

DRUG

Smoked cannabis

Sponsors & Collaborators

  • Center for Medicinal Cannabis Research

    lead OTHER

Principal Investigators

  • Ronald Ellis, M.D., Ph.D. · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2001-09-30
Primary Completion
2006-11-30
Completion
2006-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00255580 on ClinicalTrials.gov